NCOA3 and colorectal carcinoma: Altogether, these results indicated that the expression of MAD2L2 was inversely related to that of NCOA3 in CRC, and MAD2L2 was associated with good prognosis in CRC patients, which suggested that MAD2L2 might inhibit the development of CRC.